Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia

[1]  H. Shiina,et al.  Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis. , 2004, The Journal of urology.

[2]  M. Pagano,et al.  Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  T. McDonnell,et al.  The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo , 2000, Oncogene.

[4]  A. Borkowski,et al.  alpha1-ADRENOCEPTOR ANTAGONISTS TERAZOSIN AND DOXAZOSIN INDUCE PROSTATE APOPTOSIS WITHOUT AFFECTING CELL PROLIFERATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA , 1999 .

[5]  C. Cordon-Cardo,et al.  Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. , 1999, Journal of the National Cancer Institute.

[6]  J. Kozlowski,et al.  The pathogenesis of benign prostatic hyperplasia: a proposed hypothesis and critical evaluation. , 1998, The Journal of urology.

[7]  S. Haldar,et al.  The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. , 1998, Molecular human reproduction.

[8]  M. Meseguer,et al.  MUC1 and endometrial receptivity. , 1998, Molecular human reproduction.

[9]  D. Grignon,et al.  Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[10]  Colombel,et al.  Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia. , 1998, British journal of urology.

[11]  J. Brooks,et al.  CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  A. Borkowski,et al.  Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia. , 1998, The Journal of urology.

[13]  Yanping,et al.  Loss of the Cyclin-dependent Kinase Inhibitor 27Kq Protein in Human Prostate Cancer Correlates with Tumor Grade’ , 2005 .

[14]  T. Senge,et al.  Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. , 1997, The Journal of urology.

[15]  E. Gelmann,et al.  Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation. , 1997, The Journal of urology.

[16]  T. Jacks,et al.  The cell cycle and cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Kortt,et al.  The economics of benign prostatic hyperplasia treatment: a literature review. , 1996, Clinical therapeutics.

[18]  S. Korsmeyer,et al.  Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.

[19]  N. Kyprianou,et al.  Apoptotic versus proliferative activities in human benign prostatic hyperplasia. , 1996, Human pathology.

[20]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[21]  F. S. Pardo,et al.  Cyclin D1 induced apoptosis maintains the integrity of the G1/S checkpoint following ionizing radiation irradiation , 1996, Somatic cell and molecular genetics.

[22]  S. Frizelle,et al.  Proliferative activity in benign and neoplastic prostatic epithelium , 1994, The Journal of pathology.

[23]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[24]  J. McNeal,et al.  Pathology of benign prostatic hyperplasia. Insight into etiology. , 1990, The Urologic clinics of North America.

[25]  H. Perlman,et al.  An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis , 1999, Cell Death and Differentiation.

[26]  S. Haldar,et al.  The relationship between Bcl 2 , Bax and p 53 : consequences for cell cycle progression and cell death , 1998 .